• Contact
  • Svenska
Genomic Medicine Sweden
  • Disease areas
    • Childhood cancer
    • Complex diseases
    • Hematology
    • Infectious diseases
    • Pharmacogenomics
    • Rare diseases
    • Solid tumours
  • Collaboration
    • Academia and infrastructures
    • Clinical studies
    • Healthcare providers and authorities
    • Industry
    • International
    • Patient organizations
    • SciLifeLab
  • IT-Informatics
    • IT – Informatics
    • Bioinformatics Analysis Tools
    • National Genomics Platform
    • Development projects and pilot studies
  • News
  • About us
    • About us
    • Organisation & governance
Select Page
GMS and Illumina collaborate to develop whole-genome sequencing for patients with acute leukemia

GMS and Illumina collaborate to develop whole-genome sequencing for patients with acute leukemia

28 May, 2020 | Press

A new study has been initiated to evaluate whole-genome and RNA-sequencing as a first line diagnostic approach for patients in Sweden with acute leukemia. The study will assess the potential of these sequencing approaches to replace current diagnostic methods in order...
More news in Swedish
Events in Swedish

Arkiv

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
Genomic Medicine Sweden logo

Genomic Medicine Sweden
c/o Research and development Unit
Department for Healthcare Governance
298 89 Kristianstad
Sweden

  • About us
  • News
  • Contact

Genomic Medicine Sweden (GMS) is a national infrastructure in precision medicine with a vision to implement precision medicine into clinical settings and strengthen the collaboration between Swedish healthcare, research and life-science industry. GMS is comprised of seven regions with university hospitals and universities with a medical faculty. Together with patient organizations, healthcare providers, universities and industry, GMS aims to translate genomic innovation, based on advanced next-generation sequencing technologies, enabling greater precision in the diagnosis, treatment and management of patients with rare disease, cancer and infectious diseases.

Follow us

© Genomic Medicine Sweden - Alla rättigheter förbehållna